# PP13 and Doppler Study to Predict Preeclampsia

> **NCT00928213** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ben-Gurion University of the Negev** · enrollment: 1000 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Low molecular weight Heparin
- **DRUG:** No Drug

## Key facts

- **NCT ID:** NCT00928213
- **Lead sponsor:** Ben-Gurion University of the Negev
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2009-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928213, "PP13 and Doppler Study to Predict Preeclampsia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00928213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*